Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Transgenics and knockouts

The last decade has provided new molecular and genetic tools for the analysis of changes in the dopamine turnover, particularly in the generation of strains of knockout mice that are deficient in various aspects of dopamine neurone development, in the cellular machinery for dopamine neurotransmission, or in other genes associated with parkinsonism in man. As several good recent reviews are available (Jankowsky et al., 2002 Eells, 2003), the present account will focus on the behavioral phenotypes associated with genetic manipulation of dopamine systems of the forebrain. [Pg.275]

Dopamine synthesis and turnover. Rather than disrupting the specification of presumptive dopamine neurones per se, an alternative strategy is to knockout key components of the cellular synthesis of dopamine production or turnover. As the rate limiting enzyme in dopamine synthesis is TH, TH knockouts offer an obvious strategy. However, deletion of the TH gene effects adrenergic, including sympathetic as well as [Pg.275]

Knockout of different components of the dopamine processing machinery of cells influences the susceptibility of mice to a variety of toxins. Thus, DAT / mice show a reduced sensitivity to MPTP (Gainetdinov et al,. 1997) whereas VMAT+/ mice exhibit an enhanced sensitivity to the toxicity of MPTP and amphetamine (Takahashi et al., 1997 Gainetdinov et al., 1998 Fumagalli et al., 1999) but not to l-DOPA (Reveron et al., 2002). [Pg.277]

Mice with deletion of the D2 receptors have typically exhibited more marked behavioral debility, including reduced locomotion and rearing, catalepsy akin to the [Pg.277]

Behavioral effects of transgenic mice that overexpress other parkin genes associated with familial PD are yet to be reported. [Pg.279]


Plum L, Wunderlich FT, Baudler S et al (2005) Transgenic and knockout mice in diabetes research novel insights into pathophysiology, limitations, and perspectives. Physiology 20 152-161... [Pg.636]

Douni E, Akassoglou K, Alexopoulou L, et al. Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J Inflamm 1995 47(l-2) 27-38. [Pg.188]

Raeber AJ, Brandner S, Klein MA, Benninger Y, Musahl C, Frigg R, Roeckl C, Fischer MB, Weissmann C, Aguzzi A. Transgenic and knockout mice in research on prion diseases. Brain Pathol 1998 8 715-733. [Pg.282]

Transgenic and knockout mice are employed to investigate the genetics of anxiety 900... [Pg.887]

Taneja P, Zhu S, Maghc D et al (2011) Transgenic and knockout mice models to reveal the functions of tumor suppressor genes. Chn Med Insights Oncol 5 235-257... [Pg.303]

Crawley JN, Paylor R (1997) A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm Behav 31 197-211... [Pg.104]

Crawley, J. N. (1999) Behavioral phenotyping of transgenic and knockout mice experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res 835, 18-26. [Pg.52]

Crawley, J. N. (2007) What s wrong with my mouse Behavioural phenotypying of transgenic and knockout mice, 2nd ed. John Wiley Sons, Inc., New Jersey. [Pg.344]

Key Words Transgenic and knockout mice neuropsychiatric disorders anxiety the neural circuitry of complex behavior SERT Pet-1 tryptophan hydroxylase 2. [Pg.537]

Liebmann C, Schrader U, Brand V (1989) Opioid receptor affinities of the blood-derived tetrapeptides hemorphin and cytochrophin. Eur J Pharmacol 166 523-526 Lin S, Boey D, Herzog H (2004) NPY and Y receptors lessons from transgenic and knockout models. Neuropeptides 38 189-200... [Pg.508]

M. E. Patti and C. R. Kahn. Lessons from transgenic and knockout animals about noninsulin dependent diabetes mellitus. TEM, 7, 311 319, 1996. [Pg.152]

Rosenberg MP, Bortner D. Why transgenic and knockout animal models should be used (for drug efficacy studies in cancer). Cancer Metastasis Rev 1998 17 295-9. [Pg.461]

Transgenic and knockout mice which develop metastases... [Pg.216]

Crawley JN. What s Wrong with My Mouse Behavioral Phenotyping of Transgenic and Knockout Mice. 2nd ed. Wilmington, DE Wiley-Liss 2007. [Pg.281]

In addition to the controlled expression of genes made possible by available expression systems and siRNA, specific control of gene expression in the whole animal has been made possible by recombinant DNA technology. These transgenic and knockout animals have been invaluable in the dissection of a number of important toxicological pathways, and are discussed further elsewhere in the encyclopedia. [Pg.1722]


See other pages where Transgenics and knockouts is mentioned: [Pg.97]    [Pg.900]    [Pg.900]    [Pg.908]    [Pg.57]    [Pg.304]    [Pg.166]    [Pg.167]    [Pg.104]    [Pg.343]    [Pg.99]    [Pg.54]    [Pg.55]    [Pg.277]    [Pg.491]    [Pg.273]    [Pg.303]    [Pg.173]    [Pg.275]    [Pg.278]    [Pg.20]    [Pg.426]    [Pg.452]    [Pg.452]    [Pg.215]    [Pg.140]    [Pg.1711]    [Pg.2766]    [Pg.372]   


SEARCH



Knockout

Knockout transgene

© 2024 chempedia.info